BRIEF-EC approves Novartis drug exjade for iron overload

ZURICH Fri Dec 21, 2012 1:26am EST

Related Topics

ZURICH Dec 21 (Reuters) - Novartis AG : * Says European commission approves exjade for iron overload in thalassemia patients with non-transfusion-dependent thalassemia

FILED UNDER: